CD4 and viral infectious disease: Similarly, viral infection with CsA treatment resulted in an increase in CD4+ and CD8+ T cells that was, respectively, 9.3- and 7.8-fold higher when compared with mock-infected mice not treated with CsA, or was, respectively, 31.1- and 15-fold higher, compared to mock-infected/CsA-treated controls.